IRCT20210608051515N2CompletedPhase 2
Evaluation of the Effectiveness of Antidepressant Agents, Venlafaxine Versus Sertraline in Patients with Epilepsy and Depression
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •Definite Diagnosis of Epilepsy based on Clinical Findings and Neurologist View
- •Positive Evaluation of Depression based on NDDI-E Questionnaire
- •Clinical Diagnosis of Moderate to Severe Depression Using Hamilton Depression Scale
Exclusion Criteria
- •Suicide Attempt in Recent Year
- •Alcohol or Substance Abuse
- •History of a Complex Mood Disorder e.g. Bipolar Disorder
- •Other Accompanying Neurological Disease
- •Evidence of Hypersensitivity to SSRIs
- •Hypertension
- •Major Kidney or Liver Dysfunction
- •Active Hemorrhage
- •Pregnancy and Breast-feeding
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Clinical evaluation of the antidepressant effect of the use of probiotics in bipolar disorderRBR-5dhhhddniversidade de São Paulo
Completed
Phase 2
?The effect of depressor septi nasi cutting in nasolabial angle and nasal tip formTip rhinoplasty.Other plastic surgery for unacceptable cosmetic appearanceIRCT201106086745N1Investigator80
Not yet recruiting
Phase 3
study on role of anti depression activity of ayurvedic medicinesCTRI/2022/08/044774Mahatma Gandhi Ayurveda College
Completed
Not Applicable
Investigating predictors of response to Transcranial Magnetic Stimulation for the treatment of depressioACTRN12610001071011Professor Paul Fitzgerald120
Completed
Not Applicable
Preliminary study of effect of Ketamine on depressive symptomsMental and behavioral disordersKCT0000865Ajou University Hospital40